How does XPC's PS Ratio compare to its peers?

XPC is expensive based on its Price-To-Sales Ratio (45.3x) compared to the peer average (9.9x).

How does XPC's PS Ratio compare vs other companies in the SE Chemicals Industry?

XPC is expensive based on its Price-To-Sales Ratio (45.3x) compared to the European Chemicals industry average (1x).

What is XPC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate XPC's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of XPC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate XPC's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

XPC Stock Overview

A biotechnology company, develops and produces forest-based capsaicin and analogues. More details

XPC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Revenue has declined by 65.7% over the past year

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (SEK15M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

XP Chemistries AB (publ) Competitors

Photocat

OM:PCAT

SEK 55.8m

Svenska Aerogel Holding

OM:AERO

SEK 62.2m

aXichem

OM:AXIC A

SEK 76.8m

Prebona

NGM:PREBON

SEK 94.6m

Price History & Performance

Summary of share price highs, lows and changes for XP Chemistries
Historical stock prices
Current Share Price	SEK 0.10
52 Week High	SEK 0.21
52 Week Low	SEK 0.03
Beta	1.38
1 Month Change	-13.04%
3 Month Change	-10.71%
1 Year Change	-25.37%
3 Year Change	-96.47%
5 Year Change	n/a
Change since IPO	-97.49%

Recent updates

Shareholder Returns

	XPC	SE Chemicals	SE Market
7D	2.6%	-4.0%	-2.7%
1Y	-25.4%	-17.1%	4.6%

Return vs Industry: XPC underperformed the Swedish Chemicals industry which returned -17.1% over the past year.

Return vs Market: XPC underperformed the Swedish Market which returned 4.6% over the past year.

Price Volatility

Is XPC's price volatile compared to industry and market?
XPC volatility
XPC Average Weekly Movement	16.5%
Chemicals Industry Average Movement	6.9%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.4%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: XPC's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: XPC's weekly volatility has decreased from 30% to 16% over the past year, but is still higher than 75% of Swedish stocks.

About the Company

Founded	Employees	CEO	Website
2018	2	Erik Nelsson	www.xpchemistries.com

XP Chemistries AB (publ), a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. XP Chemistries AB (publ) was incorporated in 2018 and is based in Sundsvall, Sweden.

XP Chemistries AB (publ) Fundamentals Summary

How do XP Chemistries's earnings and revenue compare to its market cap?
XPC fundamental statistics
Market cap	SEK 14.55m
Earnings (TTM)	-SEK 7.13m
Revenue (TTM)	SEK 320.95k

45.3x

P/S Ratio

-2.0x

P/E Ratio

Is XPC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XPC income statement (TTM)
Revenue	SEK 320.95k
Cost of Revenue	SEK 37.86k
Gross Profit	SEK 283.08k
Other Expenses	SEK 7.41m
Earnings	-SEK 7.13m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.049
Gross Margin	88.20%
Net Profit Margin	-2,221.87%
Debt/Equity Ratio	0%

How did XPC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 03:02
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

XP Chemistries AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution